首页> 外国专利> HUMAN MONOCLONAL ANTIBODIES TO CD89, ANTIGEN BINDING PORTIONS THEREOF, HYBRIDOMAS AND TRANSFECTOMAS PRODUCING THEM, TRANSGENIC CELLS EXPRESSING THEM, BISPECIFIC, MULTISPECIFIC, MOLECULE CONJUGATES, IMMUNOTOXINS AND COMPOSITIONS COMPRISING THEM, METHODS OF PRODUCTION THEREOF AND METHODS OF DETECTION THEREOF

HUMAN MONOCLONAL ANTIBODIES TO CD89, ANTIGEN BINDING PORTIONS THEREOF, HYBRIDOMAS AND TRANSFECTOMAS PRODUCING THEM, TRANSGENIC CELLS EXPRESSING THEM, BISPECIFIC, MULTISPECIFIC, MOLECULE CONJUGATES, IMMUNOTOXINS AND COMPOSITIONS COMPRISING THEM, METHODS OF PRODUCTION THEREOF AND METHODS OF DETECTION THEREOF

机译:对CD89的人类单克隆抗体,其抗原结合部分,产生它们的杂交瘤和跨膜瘤,表达它们的转基因细胞,双特异性,多特异性,分子缀合物,免疫球蛋白,药物和组合物的方法

摘要

Human monoclonal antibodies which bind specifically to Fc alpha receptor (CD89), including monoclonal antibodies which react specifically to Fc receptor for IgA of human effector cells are disclosed. The binding agents, e.g., antibodies are useful for targeting human effector cells (e.g. macrophages) against a target cell (e.g. a cancer cell, an infectious agent, etc.). For this purpose, bifunctional antibodies or heteroantibodies can be constructed containing the binding region derived from an anti-Fc-alpha receptor antibody and the binding region of a target-specific antibody. Targeted effector cells can specifically lyse target cells.
机译:公开了与Fcα受体(CD89)特异性结合的人单克隆抗体,包括与针对人效应细胞的IgA的Fc受体特异性反应的单克隆抗体。结合剂例如抗体可用于将人效应细胞(例如巨噬细胞)靶向靶细胞(例如癌细胞,感染剂等)。为此,可以构建双功能抗体或异源抗体,其包含衍生自抗Fc-α受体抗体的结合区和靶标特异性抗体的结合区。靶向效应细胞可以特异性裂解靶细胞。

著录项

  • 公开/公告号IL157274A

    专利类型

  • 公开/公告日2010-04-15

    原文格式PDF

  • 申请/专利权人 MEDAREX INC.;

    申请/专利号IL20030157274

  • 发明设计人

    申请日2003-08-06

  • 分类号A01K67/027;A61K39/395;A61K47/48;A61P1/04;A61P1/16;A61P3/10;A61P7/04;A61P7/06;A61P11/06;A61P13/08;A61P13/12;A61P15;A61P17;A61P17/02;A61P17/06;A61P17/14;A61P19/02;A61P19/08;A61P21/04;A61P25;A61P27/02;A61P27/16;A61P29;A61P31;A61P31/08;A61P31/12;A61P35;A61P35/02;A61P37;A61P37/06;A61P37/08;C07K16/28;C07K19;C12N5/10;C12N5/20;C12N15/09;C12P21/08;C12Q1/02;G01N33/68;

  • 国家 IL

  • 入库时间 2022-08-21 18:46:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号